Is LifeMD Stock a Good Investment?

LifeMD Investment Advice

LFMD

To provide specific investment advice or recommendations on LifeMD Inc stock, we recommend investors consider the following general factors when evaluating LifeMD Inc. This will help you to make an informed decision on whether to include LifeMD in one of your diversified portfolios:

Examine LifeMD's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research LifeMD's leadership team and their track record. Good management can help LifeMD navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact LifeMD's business and its evolving consumer preferences.
Compare LifeMD's performance and market position to its competitors. Analyze how LifeMD is positioned in terms of product offerings, innovation, and market share.
Check if LifeMD pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about LifeMD's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in LifeMD Inc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if LifeMD Inc is a good investment.

Sell

Buy

Strong Sell

We provide investment recommendation to complement the last-minute expert consensus on LifeMD Inc. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure LifeMD Inc is not overpriced, please verify all LifeMD Inc fundamentals, including its shares owned by insiders, gross profit, debt to equity, as well as the relationship between the price to book and cash and equivalents . Given that LifeMD Inc has a number of shares shorted of 5.57 M, we recommend you to check LifeMD market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Market Performance	Modest	Details
Volatility	Relatively risky	Details
Hype Condition	Under hyped	Details
Current Valuation	Undervalued	Details
Odds Of Distress	Below Average	Details
Economic Sensitivity	Hyperactively responds to market trends	Details
Investor Sentiment	Impartial	Details
Analyst Consensus	Strong Buy	Details
Financial Strenth (F Score)	Frail	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unlikely Manipulator	Details

Examine LifeMD Stock

Researching LifeMD's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 16.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.64. LifeMD Inc last dividend was issued on the 14th of October 2020. The entity had 1:5 split on the 14th of October 2020.

To determine if LifeMD is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding LifeMD's research are outlined below:

	LifeMD Inc is way too risky over 90 days horizon
	LifeMD Inc appears to be risky and price may revert if volatility continues
	LifeMD Inc currently holds 18.93 M in liabilities with Debt to Equity (D/E) ratio of 0.46, which is about average as compared to similar companies. LifeMD Inc has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about LifeMD's use of debt, we should always consider it together with its cash and equity.
	The entity reported the previous year's revenue of 152.55 M. Net Loss for the year was (20.6 M) with profit before overhead, payroll, taxes, and interest of 100.37 M.
	LifeMD Inc has a frail financial position based on the latest SEC disclosures
	About 16.0% of LifeMD outstanding shares are owned by corporate insiders
	Latest headline from insidermonkey.com: LifeMD, Inc. Q3 2024 Earnings Call Transcript

LifeMD Quarterly Accounts Payable

15.87 Million

LifeMD uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in LifeMD Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to LifeMD's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	27th of March 2024 Upcoming Quarterly Report	View
	10th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	27th of March 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Earnings surprises can significantly impact LifeMD's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises LifeMD's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2024-11-07	2024-09-30	-0.12	-0.14	-0.02	16
2024-03-11	2023-12-31	-0.14	-0.12	0.02	14
2024-05-08	2024-03-31	-0.15	-0.19	-0.04	26
2023-11-08	2023-09-30	-0.15	-0.2	-0.05	33
2024-08-07	2024-06-30	-0.12	-0.19	-0.07	58
2021-11-10	2021-09-30	-0.62	-0.54	0.08	12
2022-08-11	2022-06-30	-0.35	-0.45	-0.1	28
2022-05-13	2022-03-31	-0.36	-0.46	-0.1	27

Know LifeMD's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as LifeMD is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading LifeMD Inc backward and forwards among themselves. LifeMD's institutional investor refers to the entity that pools money to purchase LifeMD's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
Northern Trust Corp	2024-09-30	317.3 K
Marshall Wace Asset Management Ltd	2024-06-30	284.8 K
Nuveen Asset Management, Llc	2024-06-30	284 K
Next Century Growth Investors Llc	2024-06-30	277.6 K
Quinn Opportunity Partners Llc	2024-09-30	269 K
Bridgeway Capital Management, Llc	2024-09-30	251.2 K
Deerfield Management Co	2024-09-30	241.3 K
Bank Of New York Mellon Corp	2024-06-30	234.6 K
Acadian Asset Management Llc	2024-06-30	222.9 K
Blackrock Inc	2024-06-30	2.3 M
Vanguard Group Inc	2024-09-30	1.7 M

Note, although LifeMD's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

LifeMD's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 251.21 M.

Market Cap

295.13 Million

LifeMD's profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	(0.47)	(0.50)
Return On Capital Employed	(0.61)	(0.58)
Return On Assets	(0.35)	(0.37)
Return On Equity	(5.88)	(6.17)

The company has Profit Margin (PM) of (0.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.09) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.09.

Determining LifeMD's profitability involves analyzing its financial statements and using various financial metrics to determine if LifeMD is a good buy. For example, gross profit margin measures LifeMD's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of LifeMD's profitability and make more informed investment decisions.

Please note, the presentation of LifeMD's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, LifeMD's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of LifeMD's management manipulating its earnings.

Evaluate LifeMD's management efficiency

LifeMD Inc has return on total asset (ROA) of (0.2134) % which means that it has lost $0.2134 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.8248) %, meaning that it created substantial loss on money invested by shareholders. LifeMD's management efficiency ratios could be used to measure how well LifeMD manages its routine affairs as well as how well it operates its assets and liabilities. As of November 25, 2024, Return On Tangible Assets is expected to decline to -0.5. The current year's Return On Capital Employed is expected to grow to -0.58. At present, LifeMD's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 44.7 M, whereas Net Tangible Assets are projected to grow to (16.7 M).

	Last Reported	Projected for Next Year
Book Value Per Share	0.16	0.17
Tangible Book Value Per Share	(0.27)	(0.26)
Enterprise Value Over EBITDA	(32.49)	(34.11)
Price Book Value Ratio	80.18	84.19
Enterprise Value Multiple	(32.49)	(34.11)
Price Fair Value	80.18	84.19
Enterprise Value	266.9 M	280.2 M

LifeMD Inc has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.

Beta

1.232

Basic technical analysis of LifeMD Stock

As of the 25th of November, LifeMD secures the Downside Deviation of 5.11, risk adjusted performance of 0.0576, and Mean Deviation of 3.92. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of LifeMD Inc, as well as the relationship between them. Please verify LifeMD Inc standard deviation, value at risk, kurtosis, as well as the relationship between the jensen alpha and semi variance to decide if LifeMD Inc is priced some-what accurately, providing market reflects its recent price of 6.47 per share. Given that LifeMD Inc has jensen alpha of (0.06), we recommend you to check LifeMD's last-minute market performance to make sure the company can sustain itself at a future point.

LifeMD's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific LifeMD insiders, such as employees or executives, is commonly permitted as long as it does not rely on LifeMD's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases LifeMD insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Marc Benathen over two months ago Disposition of 200000 shares by Marc Benathen of LifeMD at 21.2 subject to Rule 16b-3
		Stefan Galluppi over two months ago Acquisition by Stefan Galluppi of 3000 shares of LifeMD at 4.93 subject to Rule 16b-3
		Dennis Wijnker over three months ago Disposition of 80000 shares by Dennis Wijnker of LifeMD at 3.78 subject to Rule 16b-3
		Macrae Calum Archibald over three months ago Insider Trading
		Eric Yecies over three months ago Disposition of 12500 shares by Eric Yecies of LifeMD subject to Rule 16b-3
		Jindal Piyush over three months ago Acquisition by Jindal Piyush of 24835 shares of LifeMD subject to Rule 16b-3
		Eric Yecies over three months ago Acquisition by Eric Yecies of 56250 shares of LifeMD subject to Rule 16b-3
		Bhatia Naveen over six months ago Acquisition by Bhatia Naveen of 500 shares of LifeMD subject to Rule 16b-3
		Nicholas Alvarez over six months ago Acquisition by Nicholas Alvarez of 75000 shares of LifeMD subject to Rule 16b-3
		Strawn John R Jr over six months ago Acquisition by Strawn John R Jr of 10000 shares of LifeMD subject to Rule 16b-3
		Walters Happy David over six months ago Purchase by Walters Happy David of 45500 shares of LifeMD
		Velge Bertrand over a year ago Purchase by Velge Bertrand of 24500 shares of LifeMD

LifeMD's Outstanding Corporate Bonds

LifeMD issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. LifeMD Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most LifeMD bonds can be classified according to their maturity, which is the date when LifeMD Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Boeing Co 2196 Corp Bond US097023DG73	View
	HSBC Holdings PLC Corp Bond US404280DR76	View
	LifePoint Health 4375 Corp Bond US53219LAS88	View
	US53219LAU35 Corp Bond US53219LAU35	View
	MGM Resorts International Corp Bond US552953CD18	View
	AerCap Global Aviation Corp Bond US00773HAA59	View

View All LifeMD Corporate Bonds

Understand LifeMD's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing LifeMD's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.0576
	Market Risk Adjusted Performance	0.1125
	Mean Deviation	3.92
	Semi Deviation	4.84
	Downside Deviation	5.11
	Coefficient Of Variation	1567.9
	Standard Deviation	5.66
	Variance	32.06
	Information Ratio	0.0407
	Jensen Alpha	(0.06)
	Total Risk Alpha	(0.54)
	Sortino Ratio	0.0451
	Treynor Ratio	0.1025
	Maximum Drawdown	35.96
	Value At Risk	(9.15)
	Potential Upside	10.94
	Downside Variance	26.14
	Semi Variance	23.39
	Expected Short fall	(4.16)
	Skewness	0.7605
	Kurtosis	2.92

	Risk Adjusted Performance	0.0576
	Market Risk Adjusted Performance	0.1125
	Mean Deviation	3.92
	Semi Deviation	4.84
	Downside Deviation	5.11
	Coefficient Of Variation	1567.9
	Standard Deviation	5.66
	Variance	32.06
	Information Ratio	0.0407
	Jensen Alpha	(0.06)
	Total Risk Alpha	(0.54)
	Sortino Ratio	0.0451
	Treynor Ratio	0.1025
	Maximum Drawdown	35.96
	Value At Risk	(9.15)
	Potential Upside	10.94
	Downside Variance	26.14
	Semi Variance	23.39
	Expected Short fall	(4.16)
	Skewness	0.7605
	Kurtosis	2.92

Consider LifeMD's intraday indicators

LifeMD intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of LifeMD stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	103548.0
	Daily Balance Of Power	0.8933
	Rate Of Daily Change	1.12
	Day Median Price	6.21
	Day Typical Price	6.29
	Price Action Indicator	0.6
	Period Momentum Indicator	0.67
	Relative Strength Index	65.4

LifeMD Corporate Filings

13A	14th of November 2024 An amended filing to the original Schedule 13G	View Verify
13A	8th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934	View Verify
10Q	7th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations	View Verify
8K	31st of October 2024 Report filed with the SEC to announce major events that shareholders should know about	View Verify

LifeMD time-series forecasting models is one of many LifeMD's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary LifeMD's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

LifeMD Stock media impact

Far too much social signal, news, headlines, and media speculation about LifeMD that are available to investors today. That information is available publicly through LifeMD media outlets and privately through word of mouth or via LifeMD internal channels. However, regardless of the origin, that massive amount of LifeMD data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of LifeMD news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of LifeMD relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to LifeMD's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive LifeMD alpha.

LifeMD Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards LifeMD can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

LifeMD Corporate Management

Alexander Mironov	President	Profile
Dennis Wijnker	Chief Officer	Profile
Tameca Brown	VP HR	Profile
Marc Benathen	Chief Officer	Profile
Varun Pathak	Chief Simpli	Profile
Shane Biffar	Chief Counsel	Profile
Jessica Friedeman	Chief Officer	Profile

When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports: